Amanet Management & Systems Ltd. logo

Amanet Management & Systems Ltd. (AMAN)

Market Closed
14 Dec, 15:14
TASE TASE
2,250. 00
ILA
+1
+0.04%
ILA
100.09M Market Cap
- P/E Ratio
0% Div Yield
157 Volume
- Eps
2,249 ILA
Previous Close
Day Range
2,249 2,250
Year Range
17.57 2,327
Want to track AMAN and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!

Summary

AMAN closed today higher at 2,250 ILA, an increase of 0.04% from yesterday's close, completing a monthly increase of 4.9% or 105 ILA. Over the past 12 months, AMAN stock gained 38.21%.
AMAN pays dividends to its shareholders, with the most recent payment made on Sep 30, 2025. The next estimated payment will be in In 3 months on Mar 30, 2026 for a total of 61.2713 ILA.
The last earnings report, released on Jul 29, 2024, exceeded the consensus estimates by 0%. On average, the company has surpassed earnings expectations by 0%, based on the last three reports.
The stock of the company had never split.
The company's stock is traded on 1 different exchanges and in various currencies, with the primary listing on TASE (ILA).

AMAN Chart

Amanet Management & Systems Ltd. (AMAN) FAQ

What is the stock price today?

The current price is 2,250.00 ILA.

On which exchange is it traded?

Amanet Management & Systems Ltd. is listed on TASE.

What is its stock symbol?

The ticker symbol is AMAN.

Does it pay dividends? What is the current yield?

Yes, It pays dividends and the current yield is 0%.

What is its market cap?

As of today, the market cap is 100.09M.

Has Amanet Management & Systems Ltd. ever had a stock split?

No, there has never been a stock split.

Amanet Management & Systems Ltd. Profile

- Industry
- Sector
Mr. Gregory Brown BSc, MBA CEO
TASE Exchange
IL0006540129 ISIN
United States Country
- Employees
15 Sep 2025 Last Dividend
- Last Split
- IPO Date

Overview

CurveBeam AI Limited is a pioneering company dedicated to advancing the field of medical imaging through innovative technology. Since its inception in 2009 and based in Hatfield, Pennsylvania, CurveBeam AI Limited has focused on developing and manufacturing specialized point-of-care weight bearing medical imaging equipment for the European and North American markets. A prominent aspect of the company's endeavors includes the integration of artificial intelligence, specifically through the creation and utilization of tools designed for bone separation and segmentation. This technological advancement is instrumental in assisting orthopedic surgeons by providing them with detailed 3D-based deformity measurements, thereby informing more accurate clinical decisions. Additionally, CurveBeam AI Limited ventures into the domain of bone microstructure analysis via its Deep Learning AI-based platform, highlighting the company's commitment to pushing the boundaries of medical imaging and analysis. Targeting orthopedic practices, imaging centers, and hospitals, CurveBeam AI Limited continues to influence and lead in the healthcare technology sector with its groundbreaking solutions.

Products and Services

  • Specialized Weight Bearing Medical Imaging Equipment

    This equipment facilitates the capturing of detailed images of the patient in a natural standing position, simulating the weight bearing state of bones and joints. This technology is pivotal for orthopedic diagnostics and pre-surgical planning, offering unprecedented insight into the true nature of musculoskeletal conditions.

  • Artificial Intelligence Tools for Bone Separation and Segmentation

    CurveBeam AI Limited's AI tools are designed to streamline and enhance the analysis of medical images. By automating the process of bone separation and segmentation, these tools reduce manual efforts and potential errors, enabling orthopedic surgeons to derive precise 3D deformity measurements crucial for accurate diagnosis and treatment planning.

  • 3D-based Deformity Measurements Technology

    Building on the capabilities provided by their AI tools, CurveBeam AI Limited offers technology that assists in transforming traditional 2D images into detailed 3D reconstructions. These 3D models are essential for a deeper understanding of complex bone deformities, allowing for improved surgical outcomes and patient care.

  • Deep Learning AI-based Platform for Bone Microstructure Analysis

    Understanding the microstructure of bone is crucial for diagnosing conditions such as osteoporosis and assessing fracture risk. CurveBeam AI Limited's advanced AI-powered platform offers a sophisticated mechanism for analyzing the intricacies of bone microstructure, presenting new opportunities for early diagnosis and personalized treatment plans.

Contact Information

Address: 2800 Bronze Drive
Phone: 267-483-8081